Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Engaging patients in clinical trials

Multilingual, multimedia content is essentials of successful clinical trial communication

Celgene building

Celgene and Juno announce ten-year cancer deal

The firms’ pact will focus on the new area of immunotherapy

- PMLiVE

Novartis launches Apple Watch app for the visually impaired

Upgraded ViaOpta app already works on iPhone and Android phones

- PMLiVE

Opdivo approved via UK’s early drug access scheme

Bristol-Myers Squibb’s immunotherapy the first lung cancer drug approved by EAMS

- PMLiVE

Merck plans expanded filing for Emend this year

Nausea and vomiting therapy more effective than placebo in 1000-patient trial

Roche Basel Switzerland

Roche planning ocrelizumab filings in early 2016

Firm claims MS candidate outperformed Merck Serono’s Rebif in two phase III trials

Eli Lilly HQ

Lilly and Immunocore ink immunotherapy R&D deal

Firms will test new joint therapy in patients with melanoma

- PMLiVE

Sobi wins European approval for oral form of orphan drug Orfadin

Expandstreatment options for rare genetic disease HT-1

Can Cinderella save us?

Basilea’s novel antibiotic reaches UK market

Zevtera can be used against a range of infections including MRSA

Recipharm appoints new sales director

Amine Tahiri joins the CMO’s development services sales team

Novartis building

Novartis buys chronic pain specialist Spinifex Pharma

Pays $200m for the Australian pharmaceutical company

The future of communications is closer than you think

Ashfield Healthcare Communications on how the way physicians learn and keep up-to-date is changing

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links